Best Health News

Advertisers



Recent comments

Who's online

There are currently 0 users and 12 guests online.
Home

The New PeerReview™ Module of the PathData® System Greatly Reduces Time Needed to Complete Preclinical Studies

Quality (68)
Helpful (65)
PDS Pathology Data Systems Ltd. has introduced a peer review program as the latest innovation to the PathData® System, an industry leading preclinical software tool. PeerReview™, the newest PathData® System module, is fully integrated and allows for the efficient and very flexible peer reviewing of preclinical safety studies, slashing the time to complete peer reviews by up to 75%. .
Technorati Tags:
Submitted by root on Fri, 2006-11-17 08:08.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Filtered words will be replaced with the filtered version of the word.
  • Lines and paragraphs break automatically.
  • You can use Textile markup to format text.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <img>
More information about formatting options

Similar entries

  • The New PeerReview™ Module of the PathData® System Greatly Reduces Time Needed to Complete Preclinical Studies
    PDS Pathology Data Systems Ltd. has introduced a peer review program as the latest innovation to the PathData® System, an industry leading preclinical software tool. PeerReview™, the newest PathData® System module, is fully integrated and allows for the efficient and very flexible peer reviewing of preclinical safety studies, slashing the time to complete peer reviews by up to 75%. (PRWeb Nov 17, 2006)Trackback URL: http://www.prweb.com/chachingpr.php/Q291cC1TcXVhLVBpZ2ctSGFsZi1NYWduLVplcm8=
  • The New PeerReview™ Module of the PathData® System Greatly Reduces Time Needed to Complete Preclinical Studies
    PDS Pathology Data Systems Ltd. has introduced a peer review program as the latest innovation to the PathData® System, an industry leading preclinical software tool. PeerReview™, the newest PathData® System module, is fully integrated and allows for the efficient and very flexible peer reviewing of preclinical safety studies, slashing the time to complete peer reviews by up to 75%. (PRWeb Nov 17, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/Q291cC1TcXVhLVBpZ2ctSGFsZi1NYWduLVplcm8=
  • The New PeerReview™ Module of the PathData® System Greatly Reduces Time Needed to Complete Preclinical Studies
    PDS Pathology Data Systems Ltd. has introduced a peer review program as the latest innovation to the PathData® System, an industry leading preclinical software tool. PeerReview™, the newest PathData® System module, is fully integrated and allows for the efficient and very flexible peer reviewing of preclinical safety studies, slashing the time to complete peer reviews by up to 75%. (PRWeb Nov 17, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/Q291cC1TcXVhLVBpZ2ctSGFsZi1NYWduLVplcm8=
  • Users Group Meeting 2007 for PDS Pathology Data Systems' PathData, ToxData and ReproData Systems Concludes with Exciting News
    Preclinical Software provider PDS Pathology Data Systems Ltd, developer of the PathData, ToxData and ReproData Systems, recently concluded its Users Group Meeting in Basel, Switzerland by welcoming its seventeen new pharmaceutical, biotech and CRO companies to the growing family of users representing all areas of the preclinical spectrum. (PRWeb Oct 22, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1TdW1tLUluc2UtTG92
  • Users Group Meeting 2007 for PDS Pathology Data Systems' PathData, ToxData and ReproData Systems Concludes with Exciting News
    Preclinical Software provider PDS Pathology Data Systems Ltd, developer of the PathData, ToxData and ReproData Systems, recently concluded its Users Group Meeting in Basel, Switzerland by welcoming its seventeen new pharmaceutical, biotech and CRO companies to the growing family of users representing all areas of the preclinical spectrum. (PRWeb Oct 22, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1TdW1tLUluc2UtTG92
  • Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development

    Medelis, an oncology contract research organization, has published a free abstract, "Preclinical Trials: A Nuanced Approach to Get Into the Clinic Faster." In the abstract, Dr. Mike McGarry, a preclinical research scientist with 35 years of experience, discusses how oncology preclinical studies are commonly viewed as straightforward investigations run exclusively by researchers who operate without true integration with preclinical, regulatory and clinical teams. He describes a nuanced preclinical study process that hinges on a well-defined rodent model, quality data, and ongoing integration between the preclinical, regulatory and clinical teams.

  • Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development

    Medelis, an oncology contract research organization, has published a free abstract, "Preclinical Trials: A Nuanced Approach to Get Into the Clinic Faster." In the abstract, Dr. Mike McGarry, a preclinical research scientist with 35 years of experience, discusses how oncology preclinical studies are commonly viewed as straightforward investigations run exclusively by researchers who operate without true integration with preclinical, regulatory and clinical teams. He describes a nuanced preclinical study process that hinges on a well-defined rodent model, quality data, and ongoing integration between the preclinical, regulatory and clinical teams.

  • Best Doctors, Inc. Puts Thomas L. Lyons, MD In Top 5% Prestigious Peer Review Picks GYN Surgeon from 1.5 Million
    After a rigorous peer review, the exclusive Best Doctors in America® 2007-2008 database includes pioneering laparoscopic GYN surgeon Thomas L. Lyons, MD, in its exclusive roster where he has been included numerous times over its 15 year history. To qualify who exactly is a "Best Doctor," the organization asks medical specialists questions like, "If you or a loved one needed a doctor in your specialty, to whom would you refer them?" Doctors have unique, "inside" perspective about who's at the top of their profession, who's up on the latest advances in their field, and therefore, where they personally would turn for state-of-the-art care when faced with a serious medical problem.